Grantclosed🌐 United StatesPAR-25-063

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Nov 6, 2024
Response deadline: May 7, 2026, 12:00 AM UTC
Type: Grant
Category: 93.242
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-063

Doc Type: synopsis

Similar past solicitations

Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
United States · Nov 21, 2024
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
United States · Nov 6, 2024
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
United States · Oct 31, 2023
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.